Historical Stock Price
OMED historical stock prices picture
OMED (OMED) has the following price history information. Looking back at OMED historical stock prices for the last five trading days, on April 16, 2019, OMED opened at $1.06, traded as high as $1.07 and as low as $0.95, and closed at $1.02. Trading volume was a total of 930.50K shares. On April 17, 2019, OMED opened at $1.03, traded as high as $1.27 and as low as $0.82, and closed at $1.07. Trading volume was a total of 6.05M shares. On April 18, 2019, OMED opened at $1.05, traded as high as $1.05 and as low as $0.92, and closed at $0.94. Trading volume was a total of 1.98M shares. On April 22, 2019, OMED opened at $0.94, traded as high as $0.94 and as low as $0.85, and closed at $0.89. Trading volume was a total of 479.90K shares. On April 23, 2019, OMED opened at $0.89, traded as high as $0.89 and as low as $0.89, and closed at $0.89. Trading volume was a total of 1.20K shares.

OMED Historical Stock Prices By Date:

OMED historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into OMED shares, starting with a $10,000 purchase of OMED, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/28/2014
End date: 04/23/2019
Start price/share: $25.64
End price/share: $0.89
Dividends collected/share: $0.00
Total return: -96.53%
Average Annual Total Return: -49.01%
Starting investment: $10,000.00
Ending investment: $347.24
Years: 4.99
Date Open High Low Close Volume
04/16/2019 $1.06 $1.07 $0.95 $1.02 930.50K
04/17/2019 $1.03 $1.27 $0.82 $1.07 6.05M
04/18/2019 $1.05 $1.05 $0.92 $0.94 1.98M
04/22/2019 $0.94 $0.94 $0.85 $0.89 479.90K
04/23/2019 $0.89 $0.89 $0.89 $0.89 1.20K
OncoMed Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. has four anti-cancer therapeutic candidates: Navicixizumab, which is a bispecific monoclonal antibody that targets and inhibits both Delta-like ligand 4, and vascular endothelial growth factor; Anti-TIGIT, which is an inhibitory receptor that stops T-cells from attacking certain tumor cells; GITRL-Fc, which is engineered using a single-gene, linkerless trimer technology that is designed to enable activation of glucocorticoid-induced tumor necrosis factor receptor-related protein; and Rosmantuzumab, which is a monoclonal antibody targeting the RSPO-LGR cancer stem cell pathway.
Date Close
04/16/2019$1.02
04/17/2019$1.07
04/18/2019$0.94
04/22/2019$0.89
04/23/2019$0.89
OMED is categorized under the Healthcare sector; below are some other companies in the same sector:

OMER Historical Stock Prices
OMI Historical Stock Prices
OMTH Historical Stock Prices
ONCE Historical Stock Prices
ONCS Historical Stock Prices
ONCY Historical Stock Prices
ONS Historical Stock Prices
ONSIU Historical Stock Prices
ONSIZ Historical Stock Prices
ONTX Historical Stock Prices

Also explore: OMED shares outstanding history

Email EnvelopeFree OMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


OMED Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.